HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esteban C Gabazza Selected Research

imidazole-4-carboxamide

1/2022The Fairy Chemical Imidazole-4-carboxamide Inhibits the Expression of Axl, PD-L1, and PD-L2 and Improves Response to Cisplatin in Melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Esteban C Gabazza Research Topics

Disease

21Neoplasms (Cancer)
08/2023 - 02/2002
21Fibrosis (Cirrhosis)
04/2023 - 03/2002
20Inflammation (Inflammations)
11/2023 - 05/2003
19Asthma (Bronchial Asthma)
01/2023 - 03/2004
19Insulin Resistance
11/2022 - 02/2002
9Infections
04/2023 - 07/2002
9Pulmonary Fibrosis (Fibrosing Alveolitis)
04/2023 - 01/2006
9Disseminated Intravascular Coagulation
06/2022 - 07/2002
9Type 2 Diabetes Mellitus (MODY)
01/2017 - 06/2002
8Idiopathic Pulmonary Fibrosis
01/2024 - 03/2002
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2023 - 01/2017
7Chronic Obstructive Pulmonary Disease (COPD)
01/2021 - 06/2012
6Acute Lung Injury
03/2024 - 10/2004
6Lung Neoplasms (Lung Cancer)
02/2023 - 10/2005
6Diabetes Mellitus
11/2022 - 01/2018
5Disease Progression
11/2022 - 06/2002
5Thrombosis (Thrombus)
06/2022 - 02/2002
5Obesity
01/2021 - 02/2002
5Pneumonia (Pneumonitis)
01/2020 - 05/2003
5Respiratory Hypersensitivity
01/2020 - 04/2012
5Atherosclerosis
10/2017 - 01/2003
4Lung Injury
04/2023 - 10/2004
4Psoriasis (Pustulosis Palmaris et Plantaris)
08/2014 - 01/2012
3Chronic Kidney Failure (Chronic Renal Failure)
10/2023 - 11/2020
3Neoplasm Metastasis (Metastasis)
02/2023 - 09/2007
3Adenocarcinoma of Lung
01/2023 - 02/2018
3Melanoma (Melanoma, Malignant)
01/2023 - 01/2011
3Stomach Neoplasms (Stomach Cancer)
04/2021 - 09/2003
3Hypoglycemia (Reactive Hypoglycemia)
01/2021 - 01/2017
3Glucose Intolerance
01/2021 - 02/2002
3Airway Remodeling
01/2018 - 07/2014
3Liver Cirrhosis (Hepatic Cirrhosis)
01/2018 - 07/2003
3Hypersensitivity (Allergy)
01/2017 - 03/2011
3Carcinoma (Carcinomatosis)
10/2016 - 04/2002
3Atopic Dermatitis (Atopic Eczema)
03/2015 - 01/2014
3Chronic Hepatitis C
02/2013 - 05/2003
3Thrombophilia
08/2009 - 02/2003
3Hyperinsulinism (Hyperinsulinemia)
11/2004 - 07/2002
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2024 - 08/2022
2Hypoxia (Hypoxemia)
09/2023 - 06/2012
2Gallstones (Gallstone)
09/2022 - 05/2022
2Rare Diseases (Rare Disease)
06/2022 - 05/2021
2Cholecystitis
05/2022 - 04/2009
2Dehydration (Water Stress)
05/2022 - 01/2017
2Hyperglycemia
05/2021 - 08/2017
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2021 - 06/2009
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2021 - 01/2016
2Body Weight (Weight, Body)
01/2021 - 12/2018

Drug/Important Bio-Agent (IBA)

20Glucose (Dextrose)FDA LinkGeneric
11/2022 - 02/2002
13CytokinesIBA
04/2023 - 03/2004
11ThrombomodulinIBA
03/2024 - 01/2003
10Bleomycin (Blenoxane)FDA LinkGeneric
04/2023 - 03/2002
8Insulin (Novolin)FDA Link
01/2021 - 07/2002
8Dacarbazine (DIC)FDA LinkGeneric
11/2015 - 07/2002
7Protein SIBA
03/2024 - 01/2016
7Proteins (Proteins, Gene)FDA Link
12/2022 - 02/2004
7AnticoagulantsIBA
06/2022 - 05/2003
7Protein CIBA
01/2015 - 01/2003
6Messenger RNA (mRNA)IBA
01/2023 - 04/2003
6Immunoglobulin E (IgE)IBA
01/2020 - 03/2004
6AllergensIBA
01/2020 - 12/2006
6OvalbuminIBA
02/2018 - 03/2004
6ThrombinFDA Link
10/2017 - 07/2002
6Hemostatics (Antihemorrhagics)IBA
02/2015 - 01/2003
6Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
10/2013 - 02/2002
5Peptides (Polypeptides)IBA
11/2023 - 01/2020
5CollagenIBA
04/2023 - 04/2006
5Matrix Metalloproteinase 2 (Gelatinase A)IBA
04/2023 - 01/2018
5EnzymesIBA
10/2017 - 02/2002
5Thromboplastin (Tissue Factor)IBA
01/2006 - 02/2002
4antithrombin III-protease complexIBA
03/2024 - 01/2003
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2024 - 06/2012
4fibrin fragment D (D-dimer)IBA
03/2024 - 01/2003
4Blood Glucose (Blood Sugar)IBA
11/2022 - 07/2002
4Tyrosine Kinase InhibitorsIBA
01/2021 - 02/2018
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2017 - 12/2007
4Fibrinogen (Factor I)FDA Link
07/2008 - 01/2003
4FibrinIBA
04/2006 - 01/2003
3Matrix Metalloproteinases (MMPs)IBA
04/2023 - 01/2004
3Immune Checkpoint ProteinsIBA
01/2023 - 07/2021
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
01/2023 - 02/2004
3Anti-Bacterial Agents (Antibiotics)IBA
09/2022 - 09/2003
3Monoclonal AntibodiesIBA
01/2022 - 08/2014
3InterleukinsIBA
02/2018 - 06/2012
3Interleukin-10 (Interleukin 10)IBA
02/2018 - 03/2011
3Protein C InhibitorIBA
10/2007 - 02/2004
3Triglycerides (Triacylglycerol)IBA
02/2004 - 08/2003
2Immune Checkpoint InhibitorsIBA
04/2024 - 08/2022
2Neutralizing AntibodiesIBA
03/2024 - 06/2009
2Biomarkers (Surrogate Marker)IBA
11/2023 - 02/2023
2LactoferrinIBA
04/2023 - 08/2003
2AntigensIBA
12/2022 - 01/2014
2Streptozocin (Streptozotocin)FDA Link
11/2022 - 01/2021
2BilirubinIBA
09/2022 - 04/2002

Therapy/Procedure

40Therapeutics
08/2023 - 06/2002
6Aftercare (After-Treatment)
05/2022 - 06/2002
4Renal Dialysis (Hemodialysis)
10/2023 - 01/2003
3Drug Therapy (Chemotherapy)
04/2024 - 07/2022
3Subcutaneous Infusions
08/2015 - 10/2004
2Intravenous Administration
08/2023 - 05/2003